NCT06243744View on ClinicalTrials.gov

Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

July 10, 2025

Study Completion Date

July 10, 2025

Conditions
Skin LaxityTissue DegenerationTissue BreakdownCollagen DegenerationCollagen Shrinkage
Interventions
DEVICE

Renuvion APR System

The Apyx Medical Corporation Renuvion/J-Plasma helium plasma family of products has received FDA clearance under 510(k) numbers K191542, K192867 for the cutting, coagulation, and ablation of soft tissue.

Trial Locations (2)

34208

LA Plastic Surgery and Dermatology, Bradenton

34237

Holcomb & Kreithen Plastic Surgery and MedSpa, Sarasota

Sponsors

Lead Sponsor

Apyx Medical
All Listed Sponsors
lead

Apyx Medical

INDUSTRY

NCT06243744 - Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery | Biotech Hunter | Biotech Hunter